MRNA Therapeutics Market: By Type (Prophylactic Vaccines, Therapeutic Vaccines, Therapeutic Drugs), By Application (Rare Genetic Diseases, Oncology, Respiratory Diseases, Infectious Diseases, Others), By Distribution Channel (Hospitals & Clinics, Research Organizations, Others), and Geography

Purchase Option

Single User License $ 4400

Multiple User License $ 6600

Corporate User License $ 8900

1.Executive Summary

2.Global MRNA Therapeutics Market Introduction

2.1.Global MRNA Therapeutics Market - Taxonomy

2.2.Global MRNA Therapeutics Market - Definitions

2.2.1.Type

2.2.2.Application

2.2.3.Distribution Channel

2.2.4.Region

3.Global MRNA Therapeutics Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Product Landscape

3.6. New Product Launches

3.7. Impact of COVID 19 on Market

4.Global MRNA Therapeutics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030

4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5.Global MRNA Therapeutics Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

5.1. Prophylactic Vaccines,

5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Therapeutic Vaccines,

5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Therapeutic Drugs

5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

6.Global MRNA Therapeutics Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

6.1. Rare Genetic Diseases,

6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Oncology,

6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Respiratory Diseases,

6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Infectious Diseases,

6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

6.5. Others

6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.5.3. Market Opportunity Analysis

7.Global MRNA Therapeutics Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

7.1. Hospitals & Clinics,

7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Research Organizations,

7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Others

7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

8.Global MRNA Therapeutics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

8.1. North America

8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Europe

8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Asia Pacific (APAC)

8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Middle East and Africa (MEA)

8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. Latin America

8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

9.North America MRNA Therapeutics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.1.1.Prophylactic Vaccines,

9.1.2.Therapeutic Vaccines,

9.1.3.Therapeutic Drugs

9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.2.1.Rare Genetic Diseases,

9.2.2.Oncology,

9.2.3.Respiratory Diseases,

9.2.4.Infectious Diseases,

9.2.5.Others

9.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.3.1.Hospitals & Clinics,

9.3.2.Research Organizations,

9.3.3.Others

9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.4.1.United States of America (USA)

9.4.2.Canada

10.Europe MRNA Therapeutics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.1.1.Prophylactic Vaccines,

10.1.2.Therapeutic Vaccines,

10.1.3.Therapeutic Drugs

10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.2.1.Rare Genetic Diseases,

10.2.2.Oncology,

10.2.3.Respiratory Diseases,

10.2.4.Infectious Diseases,

10.2.5.Others

10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.3.1.Hospitals & Clinics,

10.3.2.Research Organizations,

10.3.3.Others

10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.4.1.Germany

10.4.2.France

10.4.3.Italy

10.4.4.United Kingdom (UK)

10.4.5.Spain

11.Asia Pacific (APAC) MRNA Therapeutics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.1.1.Prophylactic Vaccines,

11.1.2.Therapeutic Vaccines,

11.1.3.Therapeutic Drugs

11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.2.1.Rare Genetic Diseases,

11.2.2.Oncology,

11.2.3.Respiratory Diseases,

11.2.4.Infectious Diseases,

11.2.5.Others

11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.3.1.Hospitals & Clinics,

11.3.2.Research Organizations,

11.3.3.Others

11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.4.1.China

11.4.2.India

11.4.3.Australia and New Zealand (ANZ)

11.4.4.Japan

11.4.5.Rest of APAC

12.Middle East and Africa (MEA) MRNA Therapeutics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.1.1.Prophylactic Vaccines,

12.1.2.Therapeutic Vaccines,

12.1.3.Therapeutic Drugs

12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.2.1.Rare Genetic Diseases,

12.2.2.Oncology,

12.2.3.Respiratory Diseases,

12.2.4.Infectious Diseases,

12.2.5.Others

12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.3.1.Hospitals & Clinics,

12.3.2.Research Organizations,

12.3.3.Others

12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.4.1.GCC Countries

12.4.2.South Africa

12.4.3.Rest of MEA

13.Latin America MRNA Therapeutics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.1.1.Prophylactic Vaccines,

13.1.2.Therapeutic Vaccines,

13.1.3.Therapeutic Drugs

13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.2.1.Rare Genetic Diseases,

13.2.2.Oncology,

13.2.3.Respiratory Diseases,

13.2.4.Infectious Diseases,

13.2.5.Others

13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.3.1.Hospitals & Clinics,

13.3.2.Research Organizations,

13.3.3.Others

13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.4.1.Brazil

13.4.2.Mexico

13.4.3.Rest of LA

14. Competition Landscape

14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis)

14.2.1.Moderna, Inc.

14.2.2.BioNTech SE

14.2.3.CureVac N.V.

14.2.4.Arcturus Therapeutics

14.2.5.Translate Bio, Inc.

14.2.6.GSK plc.

14.2.7.Argos Therapeutics Inc.

14.2.8.Sangamo Therapeutics, Inc.

14.2.9.Pfizer Inc.

14.2.10.AstraZeneca plc.

14.2.11.Sanofi

14.2.12.CRISPR Therapeutics AG

15. Research Methodology

16. Appendix and Abbreviations

Key Features of the Reports

The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments, and start-up details that are actively working in the market
The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario